A Multibiomarker Approach to Heart Failure Prognostication: A Work in Progress
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Date
2017Journal
JACC: Heart FailurePublisher
Elsevier Inc.Type
Article
Metadata
Show full item recordIdentifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016573604&doi=10.1016%2fj.jchf.2017.02.019&partnerID=40&md5=acf06496fede78f767c580792df6a4e3; http://hdl.handle.net/10713/10948ae974a485f413a2113503eed53cd6c53
10.1016/j.jchf.2017.02.019
Scopus Count
Collections
Related articles
- Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.
- Authors: Bayes-Genis A, Barallat J, Galán A, de Antonio M, Domingo M, Zamora E, Gastelurrutia P, Vila J, Peñafiel J, Gálvez-Montón C, Lupón J
- Issue date: 2015 Dec
- Brain natriuretic peptide-guided therapy in the inpatient management of decompensated heart failure.
- Authors: Saremi A, Gopal D, Maisel AS
- Issue date: 2012 Feb
- Combined approach with Doppler echocardiography and B-type natriuretic peptide to stratify prognosis of patients with decompensated systolic heart failure.
- Authors: Seo Y, Ishizu T, Kawano S, Watanabe S, Ishimitsu T, Aonuma K
- Issue date: 2008 Dec
- Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
- Authors: Ordu S, Ozhan H, Alemdar R, Aydin M, Caglar O, Yuksel H, Kandis H
- Issue date: 2012
- Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease.
- Authors: Dini FL, Buralli S, Bajraktari G, Elezi S, Duranti E, Metelli MR, Carpi A, Taddei S
- Issue date: 2010 May